Safety and efficacy of liposomal amphotericin B for treatment of complicated visceral leishmaniasis in patients … – BMC Blogs Network

Safety and efficacy of liposomal amphotericin B for treatment of complicated visceral leishmaniasis in patients
BMC Blogs Network
The disease is a worldwide health problem affecting over 70 countries with annual incidence of 0.2 – 0.4 million cases. India, Bangladesh, Sudan, South Sudan, Ethiopia and Brazil account for the majority of cases [1]. It is caused by Leishmania

Safety and efficacy of liposomal amphotericin B for treatment of complicated visceral leishmaniasis in patients … – BMC Blogs Network